HKSE - Delayed Quote HKD
INNOVENT BIO (1801.HK)
51.450
-1.000
(-1.91%)
At close: 4:08:49 PM GMT+8
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Chen (Kaixian) Independent Non-Executive Director | Other | Mar 22, 2024 | 5,346 |
| Cooney (Charles Leland) Independent Non-Executive Director | Other | Mar 22, 2024 | 45,401 |
| Ede (Hao Xi) Chief Financial Officer | Sale | Sep 27, 2024 | 3,255,616 |
| Hsu (Joyce I-Yin) Independent Non-Executive Director | Other | Mar 22, 2024 | 6,311 |
| Yu (De-Chao Michael) Chief Executive Officer | Sale | Oct 2, 2024 | 108,875,525 |
| Zhang (Qian) Director (Executive) | Conversion | Sep 27, 2024 | 934,494 |
Related Tickers
6160.HK BeiGene, Ltd.
151.500
+1.34%
9926.HK Akeso, Inc.
92.900
+5.09%
9688.HK Zai Lab Limited
26.000
+6.56%
2269.HK WuXi Biologics (Cayman) Inc.
22.700
+5.34%
1530.HK 3SBIO
12.800
+2.24%
9966.HK Alphamab Oncology
7.320
+5.17%
2142.HK HBM Holdings Limited
7.850
-3.21%
9969.HK InnoCare Pharma Limited
10.360
-1.33%
1952.HK Everest Medicines Limited
49.700
+1.84%
1177.HK SINO BIOPHARM
3.840
+0.26%